ArticleTargeted oncology2024

lnsights into Adjuvant Systemic Treatment Selection for Patients with Stage III Melanoma: Data from the Dutch Cancer Registry.

Loeki Aldenhoven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.